Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

BACKGROUND: Neo-adjuvant chemotherapy (NaCT) facilitates complete surgical resection in locally advanced breast cancer. Due to its association with improved outcome, complete pathologic response (pCR) to neo-adjuvant treatment has been accepted as a surrogate for long-term outcome in clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Hatem, Wagner, Susanne, Flake, Darl D., Robson, Mark, Schwartzberg, Lee, Sharma, Priyanka, Magliocco, Anthony, Kronenwett, Ralf, Lancaster, Johnathan M., Lanchbury, Jerry S., Gutin, Alexander, Gradishar, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000508/
https://www.ncbi.nlm.nih.gov/pubmed/31907749
http://dx.doi.org/10.1245/s10434-019-08039-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000508/
https://www.ncbi.nlm.nih.gov/pubmed/31907749
http://dx.doi.org/10.1245/s10434-019-08039-7

Ejemplares similares